JD HEALTH
06618
BEKE-W
02423
JD-SW
09618
NTES-S
09999
XIAOMI-W
01810
(Q6)Sep 30, 2024 | (FY)Mar 31, 2024 | (Q6)Sep 30, 2023 | (FY)Mar 31, 2023 | (Q6)Sep 30, 2022 | (FY)Mar 31, 2022 | (Q6)Sep 30, 2021 | (FY)Mar 31, 2021 | (Q6)Sep 30, 2020 | (FY)Mar 31, 2020 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | 199.79%6.5M | -227.32%-21.33M | -1,085.09%-6.52M | -484.39%-6.52M | -17.02%-550K | 85.00%-1.12M | -105.07%-470K | -127.95%-7.43M | -63.77%9.27M | 3.08%26.59M |
Profit adjustment | ||||||||||
Interest (income) - adjustment | ---- | -53.69%-458K | ---- | -74.27%-298K | ---- | -35.71%-171K | ---- | 5.26%-126K | ---- | -12.71%-133K |
Interest expense - adjustment | ---- | 14.88%1.19M | ---- | 18.56%1.04M | ---- | 1.16%873K | ---- | -54.84%863K | ---- | 83.57%1.91M |
Dividend (income)- adjustment | ---- | -7.31%-1.13M | ---- | -538.79%-1.05M | ---- | ---165K | ---- | ---- | ---- | ---- |
Impairment and provisions: | ---- | 51.74%5.99M | ---- | 1,129.60%3.95M | ---- | -92.85%321K | ---- | 105.21%4.49M | ---- | -25.91%2.19M |
-Impairmen of inventory (reversal) | ---- | 652.50%1.99M | ---- | 18.37%-360K | ---- | -113.11%-441K | ---- | 168.40%3.36M | ---- | --1.25M |
-Other impairments and provisions | ---- | -7.13%4M | ---- | 465.22%4.31M | ---- | -32.27%762K | ---- | 20.45%1.13M | ---- | -68.36%934K |
Revaluation surplus: | ---- | 81.13%3.05M | ---- | 202.31%1.69M | ---- | ---1.65M | ---- | ---- | ---- | ---- |
-Other fair value changes | ---- | 81.13%3.05M | ---- | 202.31%1.69M | ---- | ---1.65M | ---- | ---- | ---- | ---- |
Asset sale loss (gain): | ---- | ---- | ---- | 37.14%-22K | ---- | -1,266.67%-35K | ---- | 116.67%3K | ---- | -104.43%-18K |
-Loss (gain) on sale of property, machinery and equipment | ---- | ---- | ---- | 37.14%-22K | ---- | -1,266.67%-35K | ---- | 116.67%3K | ---- | -104.43%-18K |
Depreciation and amortization: | ---- | -1.07%4.14M | ---- | 1.04%4.19M | ---- | -7.48%4.14M | ---- | -14.28%4.48M | ---- | 164.83%5.23M |
Special items | -246.41%-4.24M | ---- | -60.90%2.9M | --523K | --7.41M | ---- | ---- | ---- | ---- | ---- |
Adjustment items | ---- | ---- | ---- | ---- | ---- | ---- | 14.25%2.89M | ---- | 20.39%2.53M | ---- |
Operating profit before the change of operating capital | 162.51%2.26M | -345.05%-8.55M | -152.82%-3.62M | 58.14%3.49M | 182.88%6.86M | -2.99%2.21M | -79.46%2.42M | -93.64%2.27M | -57.38%11.8M | 11.58%35.77M |
Change of operating capital | ||||||||||
Inventory (increase) decrease | -749.63%-10.58M | 2,667.65%9.53M | 110.00%1.63M | -103.82%-371K | -646.36%-16.29M | 154.18%9.71M | 119.81%2.98M | -645.06%-17.93M | -715.61%-15.05M | 121.33%3.29M |
Accounts receivable (increase)decrease | -134.72%-4.4M | 2.32%-11.14M | 511.71%12.66M | -146.29%-11.4M | -181.22%-3.08M | -451.85%-4.63M | 140.35%3.79M | -105.08%-839K | -2.37%-9.38M | 156.34%16.52M |
Accounts payable increase (decrease) | ---- | 573.49%3.23M | ---- | 109.33%479K | ---- | -213.10%-5.14M | ---- | 167.30%4.54M | ---- | -808.08%-6.75M |
Special items for working capital changes | 1,823.67%12.96M | ---- | -103.56%-752K | ---- | 348.29%21.1M | -319.56%-1.4M | -264.93%-8.5M | -41.27%639K | 178.48%5.15M | 142.67%1.09M |
Cash from business operations | -97.44%254K | -82.06%-8.01M | 15.32%9.91M | -687.18%-4.4M | 1,142.34%8.6M | 106.62%749K | 109.26%692K | -122.66%-11.31M | -173.85%-7.47M | 412.31%49.92M |
Hong Kong profits tax paid | ---- | -105.42%-85K | ---- | 22.48%1.57M | --1.74M | 150.10%1.28M | ---- | 68.03%-2.56M | ---- | -603.02%-8M |
China income tax paid | 66.07%-38K | 112.01%111K | 88.12%-112K | -1,550.00%-924K | ---943K | 94.67%-56K | ---- | 49.23%-1.05M | ---- | -73.95%-2.07M |
Net cash from operations | -97.80%216K | -112.66%-7.98M | 4.39%9.8M | -290.12%-3.75M | 1,256.94%9.39M | 113.23%1.97M | 109.26%692K | -137.44%-14.92M | -173.85%-7.47M | 355.71%39.85M |
Cash flow from investment activities | ||||||||||
Interest received - investment | -33.78%147K | 92.44%458K | 1,485.71%222K | 205.13%238K | -78.79%14K | 122.86%78K | 340.00%66K | -18.60%35K | -54.55%15K | 43.33%43K |
Dividend received - investment | 17.84%1.02M | 7.31%1.13M | --863K | 538.79%1.05M | ---- | --165K | ---- | ---- | ---- | ---- |
Decrease in deposits (increase) | ---- | ---- | ---- | --4.33M | ---- | ---- | ---- | ---- | ---- | ---- |
Sale of fixed assets | ---- | -97.06%2K | ---- | 36.00%68K | --61K | 194.12%50K | ---- | -94.44%17K | ---- | 282.50%306K |
Purchase of fixed assets | -153.95%-193K | -28.50%-1.29M | 89.31%-76K | -73.92%-1.01M | -341.61%-711K | 39.37%-579K | 76.53%-161K | 40.42%-955K | -10.82%-686K | 69.58%-1.6M |
Cash on investment | ---- | ---- | ---- | ---- | ---- | ---23.39M | ---- | ---- | ---- | ---- |
Net cash from investment operations | -3.77%971K | -93.65%297K | 258.65%1.01M | 119.76%4.68M | -569.47%-636K | -2,521.59%-23.67M | 85.84%-95K | 27.99%-903K | -14.51%-671K | 75.69%-1.25M |
Net cash before financing | -89.02%1.19M | -930.70%-7.68M | 23.50%10.81M | 104.26%925K | 1,366.33%8.75M | -37.13%-21.7M | 107.33%597K | -141.00%-15.82M | -185.43%-8.14M | 286.07%38.59M |
Cash flow from financing activities | ||||||||||
New borrowing | ---- | ---- | ---- | --13.21M | --13.87M | ---- | ---- | ---- | ---- | -61.21%9.81M |
Refund | 27.68%-11M | -4.20%-5.21M | ---15.21M | ---5M | ---- | ---- | ---- | ---- | ---- | -789.98%-15.1M |
Interest paid - financing | 20.02%-691K | 1.25%-1.19M | -240.16%-864K | -37.92%-1.2M | 49.20%-254K | -1.16%-873K | -53.37%-500K | 54.84%-863K | 78.82%-326K | -850.75%-1.91M |
Net cash from financing operations | 26.29%-12.76M | -282.34%-9M | -237.09%-17.31M | 284.19%4.94M | 1,043.65%12.63M | -7.76%-2.68M | -18.41%-1.34M | 71.60%-2.49M | 6.84%-1.13M | -137.45%-8.76M |
Effect of rate | 123.62%688K | 41.34%-2.67M | 60.94%-2.91M | -385.36%-4.54M | -22,696.97%-7.46M | -63.22%1.59M | -91.93%33K | 276.08%4.33M | 177.61%409K | -323.79%-2.46M |
Net Cash | -78.09%-11.57M | -384.63%-16.69M | -130.39%-6.5M | 124.05%5.86M | 2,985.29%21.38M | -33.14%-24.38M | 92.01%-741K | -161.38%-18.31M | -211.47%-9.27M | 1,024.89%29.83M |
Begining period cash | -29.34%46.62M | 2.04%65.97M | 2.04%65.97M | -26.06%64.65M | -26.06%64.65M | -13.79%87.44M | -13.79%87.44M | 36.97%101.42M | 36.97%101.42M | 2.88%74.05M |
Cash at the end | -36.82%35.73M | -29.34%46.62M | -28.02%56.56M | 2.04%65.97M | -9.41%78.57M | -26.06%64.65M | -6.30%86.73M | -13.79%87.44M | 13.09%92.56M | 36.97%101.42M |
Cash balance analysis | ||||||||||
Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | Tianshi Hong Kong Certified Public Accountants Limited | -- | Tianshi Hong Kong Certified Public Accountants Limited | -- | Tianshi Hong Kong Certified Public Accountants Limited | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Unlock the Full List